Skip to main content
Top
Published in: NeuroMolecular Medicine 1/2013

01-03-2013 | Original Paper

Composition of Soluble Misfolded Superoxide Dismutase-1 in Murine Models of Amyotrophic Lateral Sclerosis

Authors: Per Zetterström, Karin S. Graffmo, Peter M. Andersen, Thomas Brännström, Stefan L. Marklund

Published in: NeuroMolecular Medicine | Issue 1/2013

Login to get access

Abstract

A common cause of amyotrophic lateral sclerosis is mutations in superoxide dismutase-1, which provoke the disease by an unknown mechanism. We have previously found that soluble hydrophobic misfolded mutant human superoxide dismutase-1 species are enriched in the vulnerable spinal cords of transgenic model mice. The levels were broadly inversely correlated with life spans, suggesting involvement in the pathogenesis. Here, we used methods based on antihuman superoxide dismutase-1 peptide antibodies specific for misfolded species to explore the composition and amounts of soluble misfolded human superoxide dismutase-1 in tissue extracts. Mice expressing 5 different human superoxide dismutase-1 variants with widely variable structural characteristics were examined. The levels were generally higher in spinal cords than in other tissues. The major portion of misfolded superoxide dismutase-1 was shown to be monomers lacking the C57–C146 disulfide bond with large hydrodynamic volume, indicating a severely disordered structure. The remainder of the misfolded protein appeared to be non-covalently associated in 130- and 250-kDa complexes. The malleable monomers should be prone to aggregate and associate with other cellular components, and should be easily translocated between compartments. They may be the primary cause of toxicity in superoxide dismutase-1-induced amyotrophic lateral sclerosis.
Appendix
Available only for authorised users
Literature
go back to reference Andersen, P. M., & Al-Chalabi, A. (2011). Clinical genetics of amyotrophic lateral sclerosis: What do we really know? Nature Reviews Neurology, 7, 603–615.PubMedCrossRef Andersen, P. M., & Al-Chalabi, A. (2011). Clinical genetics of amyotrophic lateral sclerosis: What do we really know? Nature Reviews Neurology, 7, 603–615.PubMedCrossRef
go back to reference Andersen, P. M., Nilsson, P., Ala-Hurula, V., Keranen, M. L., Tarvainen, I., Haltia, T., et al. (1995). Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nature Genetics, 10, 61–66.PubMedCrossRef Andersen, P. M., Nilsson, P., Ala-Hurula, V., Keranen, M. L., Tarvainen, I., Haltia, T., et al. (1995). Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nature Genetics, 10, 61–66.PubMedCrossRef
go back to reference Andersen, P. M., Sims, K. B., Xin, W. W., Kiely, R., O’Neill, G., Ravits, J., et al. (2003). Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: A decade of discoveries, defects and disputes. Amyotrophic Lateral Sclerosis, 4, 62–73.PubMedCrossRef Andersen, P. M., Sims, K. B., Xin, W. W., Kiely, R., O’Neill, G., Ravits, J., et al. (2003). Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: A decade of discoveries, defects and disputes. Amyotrophic Lateral Sclerosis, 4, 62–73.PubMedCrossRef
go back to reference Bergemalm, D., Forsberg, K., Srivastava, V., Graffmo, K. S., Andersen, P. M., Brannstrom, T., et al. (2010). Superoxide dismutase-1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice. Journal of Neurochemistry, 114, 408–418.PubMedCrossRef Bergemalm, D., Forsberg, K., Srivastava, V., Graffmo, K. S., Andersen, P. M., Brannstrom, T., et al. (2010). Superoxide dismutase-1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice. Journal of Neurochemistry, 114, 408–418.PubMedCrossRef
go back to reference Bergemalm, D., Jonsson, P. A., Graffmo, K. S., Andersen, P. M., Brannstrom, T., Rehnmark, A., et al. (2006). Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models. The Journal of Neuroscience, 26, 4147–4154.PubMedCrossRef Bergemalm, D., Jonsson, P. A., Graffmo, K. S., Andersen, P. M., Brannstrom, T., Rehnmark, A., et al. (2006). Overloading of stable and exclusion of unstable human superoxide dismutase-1 variants in mitochondria of murine amyotrophic lateral sclerosis models. The Journal of Neuroscience, 26, 4147–4154.PubMedCrossRef
go back to reference Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., et al. (1997). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron, 18, 327–338.PubMedCrossRef Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., et al. (1997). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron, 18, 327–338.PubMedCrossRef
go back to reference Chattopadhyay, M., Durazo, A., Sohn, S. H., Strong, C. D., Gralla, E. B., Whitelegge, J. P., et al. (2008). Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proceedings of the National academy of Sciences of the United States of America, 105, 18663–18668.PubMedCrossRef Chattopadhyay, M., Durazo, A., Sohn, S. H., Strong, C. D., Gralla, E. B., Whitelegge, J. P., et al. (2008). Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proceedings of the National academy of Sciences of the United States of America, 105, 18663–18668.PubMedCrossRef
go back to reference Forsberg, K., Andersen, P., Marklund, S., & Brännström, T. (2011). Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathologica, 121, 623–634.PubMedCrossRef Forsberg, K., Andersen, P., Marklund, S., & Brännström, T. (2011). Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathologica, 121, 623–634.PubMedCrossRef
go back to reference Forsberg, K., Jonsson, P. A., Andersen, P. M., Bergemalm, D., Graffmo, K. S., Hultdin, M., et al. (2010). Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One, 5, e11552.PubMedCrossRef Forsberg, K., Jonsson, P. A., Andersen, P. M., Bergemalm, D., Graffmo, K. S., Hultdin, M., et al. (2010). Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One, 5, e11552.PubMedCrossRef
go back to reference Furukawa, Y., Kaneko, K., Yamanaka, K., O’Halloran, T. V., & Nukina, N. (2008). Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. The Journal of Biological Chemistry, 283, 24167–24176.PubMedCrossRef Furukawa, Y., Kaneko, K., Yamanaka, K., O’Halloran, T. V., & Nukina, N. (2008). Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. The Journal of Biological Chemistry, 283, 24167–24176.PubMedCrossRef
go back to reference Furukawa, Y., & O’Halloran, T. V. (2005). ALS mutations have the greatest destabilizing effect on the apo, reduced form of SOD1, leading to unfolding and oxidative aggregation. The Journal of Biological Chemistry, 280, 17266–17274.PubMedCrossRef Furukawa, Y., & O’Halloran, T. V. (2005). ALS mutations have the greatest destabilizing effect on the apo, reduced form of SOD1, leading to unfolding and oxidative aggregation. The Journal of Biological Chemistry, 280, 17266–17274.PubMedCrossRef
go back to reference Graffmo, K. S., Forsberg, K., Bergh, J., Birve, A., Zetterström, P., Andersen, P. M., et al. (2012). Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. Human Molecular Genetics,. doi:10.1093/hmg/dds399.PubMed Graffmo, K. S., Forsberg, K., Bergh, J., Birve, A., Zetterström, P., Andersen, P. M., et al. (2012). Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis. Human Molecular Genetics,. doi:10.​1093/​hmg/​dds399.PubMed
go back to reference Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., et al. (1994). Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 264, 1772–1775.PubMedCrossRef Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., et al. (1994). Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science, 264, 1772–1775.PubMedCrossRef
go back to reference Hoffman, E. K., Wilcox, H. M., Scott, R. W., & Siman, R. (1996). Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 139, 15–20.PubMedCrossRef Hoffman, E. K., Wilcox, H. M., Scott, R. W., & Siman, R. (1996). Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 139, 15–20.PubMedCrossRef
go back to reference Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009). Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. The Journal of Cell Biology, 187, 761–772.PubMedCrossRef Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009). Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. The Journal of Cell Biology, 187, 761–772.PubMedCrossRef
go back to reference Israelson, A., Arbel, N., Da Cruz, S., Ilieva, H., Yamanaka, K., Shoshan-Barmatz, V., et al. (2010). Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron, 67, 575–587.PubMedCrossRef Israelson, A., Arbel, N., Da Cruz, S., Ilieva, H., Yamanaka, K., Shoshan-Barmatz, V., et al. (2010). Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron, 67, 575–587.PubMedCrossRef
go back to reference Johnston, J. A., Dalton, M. J., Gurney, M. E., & Kopito, R. R. (2000). Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proceedings of the National academy of Sciences of the United States of America, 97, 12571–12576.PubMedCrossRef Johnston, J. A., Dalton, M. J., Gurney, M. E., & Kopito, R. R. (2000). Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proceedings of the National academy of Sciences of the United States of America, 97, 12571–12576.PubMedCrossRef
go back to reference Jonsson, P. A., Ernhill, K., Andersen, P. M., Bergemalm, D., Brannstrom, T., Gredal, O., et al. (2004). Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain, 127, 73–88.PubMedCrossRef Jonsson, P. A., Ernhill, K., Andersen, P. M., Bergemalm, D., Brannstrom, T., Gredal, O., et al. (2004). Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain, 127, 73–88.PubMedCrossRef
go back to reference Jonsson, P. A., Graffmo, K. S., Andersen, P. M., Brannstrom, T., Lindberg, M., Oliveberg, M., et al. (2006a). Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain, 129, 451–464.PubMedCrossRef Jonsson, P. A., Graffmo, K. S., Andersen, P. M., Brannstrom, T., Lindberg, M., Oliveberg, M., et al. (2006a). Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain, 129, 451–464.PubMedCrossRef
go back to reference Jonsson, P. A., Graffmo, K. S., Brannstrom, T., Nilsson, P., Andersen, P. M., & Marklund, S. L. (2006b). Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1. Journal of Neuropathology and Experimental Neurology, 65, 1126–1136.PubMedCrossRef Jonsson, P. A., Graffmo, K. S., Brannstrom, T., Nilsson, P., Andersen, P. M., & Marklund, S. L. (2006b). Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1. Journal of Neuropathology and Experimental Neurology, 65, 1126–1136.PubMedCrossRef
go back to reference Kabuta, T., Suzuki, Y., & Wada, K. (2006). Degradation of amyotrophic lateral sclerosis-linked mutant Cu, Zn-superoxide dismutase proteins by macroautophagy and the proteasome. The Journal of Biological Chemistry, 281, 30524–30533.PubMedCrossRef Kabuta, T., Suzuki, Y., & Wada, K. (2006). Degradation of amyotrophic lateral sclerosis-linked mutant Cu, Zn-superoxide dismutase proteins by macroautophagy and the proteasome. The Journal of Biological Chemistry, 281, 30524–30533.PubMedCrossRef
go back to reference Kanning, K. C., Kaplan, A., & Henderson, C. E. (2010). Motor neuron diversity in development and disease. Annual Review of Neuroscience, 33, 409–440.PubMedCrossRef Kanning, K. C., Kaplan, A., & Henderson, C. E. (2010). Motor neuron diversity in development and disease. Annual Review of Neuroscience, 33, 409–440.PubMedCrossRef
go back to reference Karch, C. M., Prudencio, M., Winkler, D. D., Hart, P. J., & Borchelt, D. R. (2009). Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proceedings of the National academy of Sciences of the United States of America, 106, 7774–7779.PubMedCrossRef Karch, C. M., Prudencio, M., Winkler, D. D., Hart, P. J., & Borchelt, D. R. (2009). Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proceedings of the National academy of Sciences of the United States of America, 106, 7774–7779.PubMedCrossRef
go back to reference Kay, A. (2004). Detecting and minimizing zinc contamination in physiological solutions. BMC Physiology, 4, 4.PubMedCrossRef Kay, A. (2004). Detecting and minimizing zinc contamination in physiological solutions. BMC Physiology, 4, 4.PubMedCrossRef
go back to reference Kayatekin, C., Zitzewitz, J. A., & Matthews, C. R. (2008). Zinc binding modulates the entire folding free energy surface of human Cu, Zn superoxide dismutase. Journal of Molecular Biology, 384, 540–555.PubMedCrossRef Kayatekin, C., Zitzewitz, J. A., & Matthews, C. R. (2008). Zinc binding modulates the entire folding free energy surface of human Cu, Zn superoxide dismutase. Journal of Molecular Biology, 384, 540–555.PubMedCrossRef
go back to reference Lindberg, M. J., Normark, J., Holmgren, A., & Oliveberg, M. (2004). Folding of human superoxide dismutase: Disulfide reduction prevents dimerization and produces marginally stable monomers. Proceedings of the National academy of Sciences of the United States of America, 101, 15893–15898.PubMedCrossRef Lindberg, M. J., Normark, J., Holmgren, A., & Oliveberg, M. (2004). Folding of human superoxide dismutase: Disulfide reduction prevents dimerization and produces marginally stable monomers. Proceedings of the National academy of Sciences of the United States of America, 101, 15893–15898.PubMedCrossRef
go back to reference Mondola, P., Annella, T., Santillo, M., & Santangelo, F. (1996). Evidence for secretion of cytosolic CuZn superoxide dismutase by Hep G2 cells and human fibroblasts. The International Journal of Biochemistry and Cell Biology, 28, 677–681.CrossRef Mondola, P., Annella, T., Santillo, M., & Santangelo, F. (1996). Evidence for secretion of cytosolic CuZn superoxide dismutase by Hep G2 cells and human fibroblasts. The International Journal of Biochemistry and Cell Biology, 28, 677–681.CrossRef
go back to reference Mourelatos, Z., Gonatas, N. K., Stieber, A., Gurney, M. E., & Dal Canto, M. C. (1996). The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu, Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proceedings of the National academy of Sciences of the United States of America, 93, 5472–5477.PubMedCrossRef Mourelatos, Z., Gonatas, N. K., Stieber, A., Gurney, M. E., & Dal Canto, M. C. (1996). The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu, Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proceedings of the National academy of Sciences of the United States of America, 93, 5472–5477.PubMedCrossRef
go back to reference Mulligan, V. K., Kerman, A., Ho, S., & Chakrabartty, A. (2008). Denaturational stress induces formation of zinc-deficient monomers of Cu, Zn superoxide dismutase: Implications for pathogenesis in amyotrophic lateral sclerosis. Journal of Molecular Biology, 383, 424–436.PubMedCrossRef Mulligan, V. K., Kerman, A., Ho, S., & Chakrabartty, A. (2008). Denaturational stress induces formation of zinc-deficient monomers of Cu, Zn superoxide dismutase: Implications for pathogenesis in amyotrophic lateral sclerosis. Journal of Molecular Biology, 383, 424–436.PubMedCrossRef
go back to reference Nordlund, A., Leinartaitė, L., Saraboji, K., Aisenbrey, C., Gröbner, G., Zetterström, P., et al. (2009). Functional features cause misfolding of the ALS-provoking enzyme SOD1. Proceedings of the National academy of Sciences of the United States of America, 106, 9667–9672.PubMedCrossRef Nordlund, A., Leinartaitė, L., Saraboji, K., Aisenbrey, C., Gröbner, G., Zetterström, P., et al. (2009). Functional features cause misfolding of the ALS-provoking enzyme SOD1. Proceedings of the National academy of Sciences of the United States of America, 106, 9667–9672.PubMedCrossRef
go back to reference Pasinelli, P., Belford, M. E., Lennon, N., Bacskai, B. J., Hyman, B. T., Trotti, D., et al. (2004). Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron, 43, 19–30.PubMedCrossRef Pasinelli, P., Belford, M. E., Lennon, N., Bacskai, B. J., Hyman, B. T., Trotti, D., et al. (2004). Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron, 43, 19–30.PubMedCrossRef
go back to reference Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59–62.PubMedCrossRef Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59–62.PubMedCrossRef
go back to reference Rumfeldt, J. A. O., Lepock, J. R., & Meiering, E. M. (2009). Unfolding and folding kinetics of amyotrophic lateral sclerosis-associated mutant Cu, zn superoxide dismutases. Journal of Molecular Biology, 385, 278–298.PubMedCrossRef Rumfeldt, J. A. O., Lepock, J. R., & Meiering, E. M. (2009). Unfolding and folding kinetics of amyotrophic lateral sclerosis-associated mutant Cu, zn superoxide dismutases. Journal of Molecular Biology, 385, 278–298.PubMedCrossRef
go back to reference Urushitani, M., Sik, A., Sakurai, T., Nukina, N., Takahashi, R., & Julien, J. P. (2006). Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nature Neuroscience, 9, 108–118.PubMedCrossRef Urushitani, M., Sik, A., Sakurai, T., Nukina, N., Takahashi, R., & Julien, J. P. (2006). Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nature Neuroscience, 9, 108–118.PubMedCrossRef
go back to reference Uversky, V. N., & Ptitsyn, O. B. (1996). Further evidence on the equilibrium “Pre-molten Globule State”: Four-state guanidinium chloride-induced unfolding of carbonic anhydrase b at low temperature. Journal of Molecular Biology, 255, 215–228.PubMedCrossRef Uversky, V. N., & Ptitsyn, O. B. (1996). Further evidence on the equilibrium “Pre-molten Globule State”: Four-state guanidinium chloride-induced unfolding of carbonic anhydrase b at low temperature. Journal of Molecular Biology, 255, 215–228.PubMedCrossRef
go back to reference Williamson, T. L., & Cleveland, D. W. (1999). Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nature Neuroscience, 2, 50–56.PubMedCrossRef Williamson, T. L., & Cleveland, D. W. (1999). Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nature Neuroscience, 2, 50–56.PubMedCrossRef
go back to reference Wooley, C. M., Sher, R. B., Kale, A., Frankel, W. N., Cox, G. A., & Seburn, K. L. (2005). Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle and Nerve, 32, 43–50.PubMedCrossRef Wooley, C. M., Sher, R. B., Kale, A., Frankel, W. N., Cox, G. A., & Seburn, K. L. (2005). Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle and Nerve, 32, 43–50.PubMedCrossRef
go back to reference Wroe, R., Wai-Ling Butler, A., Andersen, P. M., Powell, J. F., & Al-Chalabi, A. (2008). ALSOD: The amyotrophic lateral sclerosis online database. Amyotrophic Lateral Sclerosis, 9, 249–250.PubMedCrossRef Wroe, R., Wai-Ling Butler, A., Andersen, P. M., Powell, J. F., & Al-Chalabi, A. (2008). ALSOD: The amyotrophic lateral sclerosis online database. Amyotrophic Lateral Sclerosis, 9, 249–250.PubMedCrossRef
go back to reference Zetterstrom, P., Andersen, P. M., Brannstrom, T., & Marklund, S. L. (2011a). Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients. Journal of Neurochemistry, 117, 91–99.PubMedCrossRef Zetterstrom, P., Andersen, P. M., Brannstrom, T., & Marklund, S. L. (2011a). Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients. Journal of Neurochemistry, 117, 91–99.PubMedCrossRef
go back to reference Zetterstrom, P., Graffmo, K. S., Andersen, P. M., Brannstrom, T., & Marklund, S. L. (2011b). Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic ALS model mice. The Journal of Biological Chemistry, 286, 20130–20136.PubMedCrossRef Zetterstrom, P., Graffmo, K. S., Andersen, P. M., Brannstrom, T., & Marklund, S. L. (2011b). Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic ALS model mice. The Journal of Biological Chemistry, 286, 20130–20136.PubMedCrossRef
go back to reference Zetterstrom, P., Stewart, H. G., Bergemalm, D., Jonsson, P. A., Graffmo, K. S., Andersen, P. M., et al. (2007). Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proceedings of the National academy of Sciences of the United States of America, 104, 14157–14162.PubMedCrossRef Zetterstrom, P., Stewart, H. G., Bergemalm, D., Jonsson, P. A., Graffmo, K. S., Andersen, P. M., et al. (2007). Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proceedings of the National academy of Sciences of the United States of America, 104, 14157–14162.PubMedCrossRef
go back to reference Zhang, F., Strom, A. L., Fukada, K., Lee, S., Hayward, L. J., & Zhu, H. (2007). Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. The Journal of Biological Chemistry, 282, 16691–16699.PubMedCrossRef Zhang, F., Strom, A. L., Fukada, K., Lee, S., Hayward, L. J., & Zhu, H. (2007). Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. The Journal of Biological Chemistry, 282, 16691–16699.PubMedCrossRef
Metadata
Title
Composition of Soluble Misfolded Superoxide Dismutase-1 in Murine Models of Amyotrophic Lateral Sclerosis
Authors
Per Zetterström
Karin S. Graffmo
Peter M. Andersen
Thomas Brännström
Stefan L. Marklund
Publication date
01-03-2013
Publisher
Humana Press Inc
Published in
NeuroMolecular Medicine / Issue 1/2013
Print ISSN: 1535-1084
Electronic ISSN: 1559-1174
DOI
https://doi.org/10.1007/s12017-012-8204-z

Other articles of this Issue 1/2013

NeuroMolecular Medicine 1/2013 Go to the issue